Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases.: Where and how do cysteine proteases express their selectivity?

被引:17
作者
Czaplewski, C
Grzonka, Z
Jaskólski, M
Kasprzykowski, F
Kozak, M
Politowska, E
Ciarkowski, J
机构
[1] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland
[2] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland
[3] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1999年 / 1431卷 / 02期
关键词
thiol protease; enzyme selectivity; covalent protease inhibitor; molecular dynamics; constrained simulated annealing;
D O I
10.1016/S0167-4838(99)00053-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Papain from Carica papaya, an easily available cysteine protease, is the best-studied representative of this family of enzymes. The three dimensional structure of papain is very similar to that of other cysteine proteases of either plant (actinidin, caricain, papaya protease IV) or animal (cathepsins B, K, L, H) origin. As abnormalities in the activities of mammalian cysteine proteases accompany a variety of diseases, there has been a long-lasting interest in the development of potent and selective inhibitors for these enzymes. A covalent inhibitor of cysteine proteases, designed as a combination of epoxysuccinyl and peptide moieties, has been modeled in the catalytic pocket of papain. A number of its configurations have been generated and relaxed by constrained simulated annealing-molecular dynamics in water. A clear conformational variability of this inhibitor is discussed in the context of a conspicuous conformational diversity observed earlier in several solid-state structures of other complexes between cysteine proteases and covalent inhibitors. The catalytic pockets S2 and even more so S3, as defined by the pioneering studies on the papain-ZPACK, papain-E64c and papain-leupeptin complexes, appear elusive in view of the evident flexibility of the present inhibitor and in confrontation with the obvious conformational scatter seen in other examples. This predicts limited chances for the development of selective structure-based inhibitors of thiol proteases, designed to exploit the minute differences in the catalytic pockets of various members of this family. A simultaneous comparison of the three published proenzyme structures suggests the enzyme's prosegment binding loop-prosegment interface as a new potential target for selective inhibitors of papain-related thiol proteases, (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:290 / 305
页数:16
相关论文
共 46 条
[1]  
Baker E.N., 1987, BIOL MACROMOL, V3, P314
[2]   STRUCTURE OF ACTINIDIN, AFTER REFINEMENT AT 1.7-A RESOLUTION [J].
BAKER, EN .
JOURNAL OF MOLECULAR BIOLOGY, 1980, 141 (04) :441-484
[3]   A WELL-BEHAVED ELECTROSTATIC POTENTIAL BASED METHOD USING CHARGE RESTRAINTS FOR DERIVING ATOMIC CHARGES - THE RESP MODEL [J].
BAYLY, CI ;
CIEPLAK, P ;
CORNELL, WD ;
KOLLMAN, PA .
JOURNAL OF PHYSICAL CHEMISTRY, 1993, 97 (40) :10269-10280
[4]   MOLECULAR-DYNAMICS WITH COUPLING TO AN EXTERNAL BATH [J].
BERENDSEN, HJC ;
POSTMA, JPM ;
VANGUNSTEREN, WF ;
DINOLA, A ;
HAAK, JR .
JOURNAL OF CHEMICAL PHYSICS, 1984, 81 (08) :3684-3690
[5]  
*CHEM DES, 1994, CHEM X VERS JAN 94
[6]   MULTIPLE SEQUENCE ALIGNMENT WITH HIERARCHICAL-CLUSTERING [J].
CORPET, F .
NUCLEIC ACIDS RESEARCH, 1988, 16 (22) :10881-10890
[7]   Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment [J].
Coulombe, R ;
Grochulski, P ;
Sivaraman, J ;
Menard, R ;
Mort, JS ;
Cygler, M .
EMBO JOURNAL, 1996, 15 (20) :5492-5503
[8]   Structure of rat procathepsin B: Model for inhibition of cysteine protease activity by the proregion [J].
Cygler, M ;
Sivaraman, J ;
Grochulski, P ;
Coulombe, R ;
Storer, AC ;
Mort, JS .
STRUCTURE, 1996, 4 (04) :405-416
[9]   INVIVO AND INVITRO EVIDENCE FOR THE INVOLVEMENT OF CYSTEINE PROTEINASES IN BONE-RESORPTION [J].
DELAISSE, JM ;
EECKHOUT, Y ;
VAES, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 125 (02) :441-447
[10]  
DENHARDT DT, 1987, ONCOGENE, V2, P55